Discover Magazine - March 27, 2021
Dawn Buse, Ph.D., describes the triggers and phases of migraines and explains that a variety of treatments are available to people who suffer from the debilitating headaches. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology.
Dr. Buse's ProfileMore coverage on Dr. Buse
The Scientist - March 24, 2021
Stephanie Rudolph, Ph.D., discusses a study that confirms the relationship between the size of synapses in the brain and their strength, which has implications for memory and learning. Dr. Rudolph is assistant professor in the Dominick P. Purpura Department of Neuroscience and of psychiatry and behavioral sciences.
Dr. Rudolph's ProfileMore coverage on Dr. Rudolph
US News & World Report - March 18, 2021
Sofiya Milman, M.D., M.S., comments on recent research that confirmed people age at different rates. She notes that both genes and factors such as poverty, stress, diet, and exercise influence how fast or slowly a person's body systems age and decline. Dr. Milman is associate professor of medicine and of genetics and is director of human longevity studies at the Institute for Aging Research.
Dr. Milman's ProfileMore coverage on Dr. Milman
BronxNet - March 16, 2021
Edward Chu, M.D., discusses the importance of regular colorectal cancer screening for those over 45, as well as the disease's risk factors and prevalence. Dr. Chu is director of the Albert Einstein Cancer Center, vice president for cancer medicine at Montefiore Medicine, professor of medicine and of molecular pharmacology and is the Carol and Roger Einiger Professor of Cancer Medicine at Einstein.
Dr. Chu's ProfileMore coverage on Dr. Chu
The Wall Street Journal - March 11, 2021
David Sharp, Ph.D., discusses a drug, discovered in his lab and licensed to a company he co-founded, that in preclinical studies helped regenerate nerve cells damaged in spinal-cord injuries. Dr. Sharp is professor of physiology & biophysics, of ophthalmology and visual sciences, and in the Dominick P. Purpura Department of Neuroscience.
Dr. Sharp's ProfileMore coverage on Dr. Sharp
National Institute on Aging - March 11, 2021
Research led by Ana Maria Cuervo, M.D., Ph.D., has found that improving autophagy, the process by which cells recycle and remove waste, in blood stem cells can reverse age-related declines in the immune systems of mice—findings that may have relevance for human health. Dr. Cuervo is professor of developmental and molecular biology, of anatomy and structural biology, and of medicine, co-director of the Institute for Aging Research, and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein.
Dr. Cuervo's ProfileMore coverage on Dr. Cuervo
Newsweek - March 8, 2021
Susan Band Horwitz, Ph.D., is featured as one of seven women who changed science. Dr. Horwitz is recognized for her discovery of the mechanism for action for the blockbuster cancer chemotherapeutic drug Taxol. Dr. Horwitz is distinguished professor emerita of molecular pharmacology and the Rose C. Falkenstein Professor of Cancer Research.
Dr. Horwitz's ProfileMore coverage on Dr. Horwitz
The Washington Post - March 6, 2021
Nir Barzilai, M.D., discusses his proposed clinical trial to test whether the diabetes drug metformin can delay age-related diseases such as cancer and Alzheimer's disease. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Infection Control Today - March 2, 2021
Priya Nori, M.D., talks about the re-emergence of multi-drug resistant bacteria and fungi in the wake of the COVID-19 pandemic and the important role infectious disease physicians can play in preventing outbreaks and ensuring patient safety. Dr. Nori is associate professor of medicine and of orthopaedics at Einstein and medical director of the antimicrobial stewardship program at Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
ABC 7 NY - February 3, 2021
Montefiore and Einstein will receive $13 million from New York City as part of its investment in new biotech centers. The Einstein-Montefiore Biotechnology Accelerated Research Center (EMBARC) will establish a biomanufacturing operation focused on cell, gene, and antibody therapy production and will provide scientific facilities to early-stage and established companies.
Additional Coverage includes AMNY, New York Business Journal, Connect New York, Patch.com, Yahoo News, and WPIX11
The Scientist - January 8, 2021
Kartik Chandran, Ph.D., talks about the future of COVID-19 research, including the development of treatments and vaccines to treat and prevent the novel coronavirus as it mutates over time. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
The New York Times - January 6, 2021
Liise-anne Pirofski, M.D., discusses a small Argentinian clinical trial that found convalescent plasma was effective in reducing the risk of severe COVID-19 in older patients if they received the treatment within three days of showing symptoms. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
Los Angeles Times - November 19, 2020
Eric Meyerowitz, M.D., discusses his study suggesting that transmission of COVID-19 most often occurs indoors in poorly ventilated spaces, with a large portion originating from people who don’t show symptoms. Dr. Meyerowitz is assistant professor of medicine at Einstein and an internist and infectious disease specialist at Montefiore.
Dr. Meyerowitz's Profile